TRAINI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 708
EU - Europa 173
AS - Asia 115
SA - Sud America 2
Totale 998
Nazione #
US - Stati Uniti d'America 706
CN - Cina 54
IT - Italia 39
DE - Germania 33
SG - Singapore 29
UA - Ucraina 26
SE - Svezia 23
PL - Polonia 22
TR - Turchia 20
GB - Regno Unito 15
ID - Indonesia 7
FI - Finlandia 6
IN - India 4
NL - Olanda 3
BR - Brasile 2
CA - Canada 2
FR - Francia 2
LT - Lituania 2
BE - Belgio 1
ES - Italia 1
IR - Iran 1
Totale 998
Città #
Fairfield 121
Woodbridge 84
Ashburn 67
Houston 67
Chandler 56
Seattle 52
Wilmington 46
Jacksonville 34
Cambridge 33
Warsaw 22
Izmir 19
Singapore 19
Ann Arbor 16
Nanjing 15
Bremen 13
Princeton 13
Milan 12
Dearborn 10
Ferrara 10
Shanghai 9
Beijing 8
Jakarta 7
San Diego 6
Boardman 5
Tianjin 4
Los Angeles 3
Nanchang 3
New York 3
Shenyang 3
Delft 2
Des Moines 2
Forlì 2
Formigine 2
Frankfurt am Main 2
Guangzhou 2
London 2
Mumbai 2
Ningbo 2
Reggio Emilia 2
Rio de Janeiro 2
Santa Clara 2
Vicenza 2
Ardabil 1
Brussels 1
Changsha 1
Clifton 1
Delhi 1
Falls Church 1
Ferrara di Monte Baldo 1
Forest City 1
Hefei 1
Jiaxing 1
Kilburn 1
Kunming 1
Lanzhou 1
Lyon 1
Mcallen 1
Miami Beach 1
Munich 1
Norwalk 1
Ottawa 1
San Mateo 1
Santa Lucia Di Piave 1
Shaoxing 1
Taizhou 1
The Hague 1
Toronto 1
Voghiera 1
Walnut 1
Washington 1
Yellow Springs 1
Totale 815
Nome #
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 153
Co-spray dried resveratrol and budesonide inhalation formulation for reducing inflammation and oxidative stress in rat alveolar macrophages 136
Solid lipid microparticles as an approach to drug delivery 124
Quercetin Solid Lipid Microparticles: a flavonoid for inhalation lung delivery 107
Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study 95
Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection 87
null 86
The use of fatty acids as absorption enhancer for pulmonary drug delivery 82
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 73
Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis 25
In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation 22
A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties 21
Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler 18
Co-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder Formulation 16
Totale 1.045
Categoria #
all - tutte 5.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020144 0 0 0 0 17 29 30 23 23 13 5 4
2020/2021211 9 7 6 24 5 6 34 20 14 53 26 7
2021/202294 2 4 6 3 17 8 2 5 8 12 5 22
2022/2023132 11 4 8 13 35 16 14 5 17 0 7 2
2023/202466 11 12 4 2 3 5 2 4 1 0 0 22
2024/202559 5 7 31 2 14 0 0 0 0 0 0 0
Totale 1.045